ALPS Medical Breakthroughs ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 55.39
成立日期: 30/12/2014
 
分析
市值分佈:
49.50%
大市值
40.91%
中市值
9.61%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:10) 總持有投資項目: 85  
0%
 
100%
     10大 (33.80%)
代號 名稱 佔比% 持有日期
VERAVera Therapeutics1.6329/04/2026
IRONDisc Medicine1.6029/04/2026
IDYAIDEAYA Biosciences1.5729/04/2026
ZLABZai Lab Limited1.4729/04/2026
RLAYRelay Therapeutics1.4329/04/2026
SRPTSarepta Therapeutics1.3829/04/2026
CLDXCelldex Therapeutics1.3629/04/2026
MLYSMineralys Therapeutics1.2929/04/2026
PHVSPharvaris NV1.2229/04/2026
STOKStoke Therapeutics1.1829/04/2026
GLPGGalapagos NV1.1729/04/2026
TYRATyra Biosciences1.1629/04/2026
AMLXAmylyx Pharmaceuticals1.1029/04/2026
TSHATaysha Gene Therapies1.0929/04/2026
VCELVericel Corp1.0829/04/2026
SIONSionna Therapeutics Inc1.0729/04/2026
PVLAPalvella Therapeutics Inc1.0729/04/2026
AGIOAgios Pharmaceuticals1.0529/04/2026
RAPPRapport Therapeutics Inc.1.0029/04/2026
OCSOculis Holding AG0.9629/04/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.